Galantamine Hydrobromide

Galantamine Hydrobromide is a tertiary alkaloid originally isolated from the bulbs of Galanthus woronowii and other Amaryllidaceae species. As a reversible, competitive acetylcholinesterase inhibitor, it is widely used in the treatment of mild to moderate Alzheimer’s disease and other cognitive disorders. Our product is produced via semi-synthesis or extraction, purified to ≥98% (HPLC), and supplied as a white to off-white crystalline powder.

This API is intended for pharmaceutical formulations, including tablets, capsules, and oral solutions. Each batch is accompanied by a comprehensive COA, MSDS, and TDS, ensuring full traceability and regulatory compliance.

Synonimy: Galantamine HBr, (4aS,6R,8aS)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide, Razadyne, Reminyl, Nivalin

Zastosowania

• Pharmaceutical formulations for cognitive enhancement and Alzheimer’s disease treatment
• Research and development in neuropharmacology
• Compounding pharmacies for customized dosage forms

Jakość i dokumentacja

Every batch is tested for assay (HPLC ≥98%), loss on drying (≤0.5%), and heavy metals (≤10 ppm). Full COA, MSDS, and TDS are available on request; stability data can be provided for qualification.

Opakowania i zaopatrzenie

Standardowe opakowania: 1 kg, 5 kg, 25 kg. Możliwość dostosowania opakowań oraz dostaw luzem. Produkty dostępne w magazynie wysyłamy w ciągu 3–5 dni. Minimalna wielkość zamówienia (MOQ) od 1 kg. W sprawie cen, próbek lub zamówień hurtowych prosimy o kontakt z naszym działem sprzedaży.

Zapytanie ofertowe

• Nasz adres: 280 Main Street, Xi’an, Shaanxi, Chiny
• LyvBio Sp. z o.o. — E-mail: info@lyvbio.com